SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Pharoah Paul D. P.) ;mspu:(article)"

Sökning: WFRF:(Pharoah Paul D. P.) > Tidskriftsartikel

  • Resultat 1-10 av 79
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  •  
3.
  •  
4.
  •  
5.
  •  
6.
  •  
7.
  • Hollestelle, Antoinette, et al. (författare)
  • No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer
  • 2016
  • Ingår i: Gynecologic Oncology. - : Elsevier BV. - 0090-8258 .- 1095-6859. ; 141:2, s. 386-401
  • Tidskriftsartikel (refereegranskat)abstract
    • Objective Clinical genetic testing is commercially available for rs61764370, an inherited variant residing in a KRAS 3′ UTR microRNA binding site, based on suggested associations with increased ovarian and breast cancer risk as well as with survival time. However, prior studies, emphasizing particular subgroups, were relatively small. Therefore, we comprehensively evaluated ovarian and breast cancer risks as well as clinical outcome associated with rs61764370. Methods Centralized genotyping and analysis were performed for 140,012 women enrolled in the Ovarian Cancer Association Consortium (15,357 ovarian cancer patients; 30,816 controls), the Breast Cancer Association Consortium (33,530 breast cancer patients; 37,640 controls), and the Consortium of Modifiers of BRCA1 and BRCA2 (14,765 BRCA1 and 7904 BRCA2 mutation carriers). Results We found no association with risk of ovarian cancer (OR = 0.99, 95% CI 0.94-1.04, p = 0.74) or breast cancer (OR = 0.98, 95% CI 0.94-1.01, p = 0.19) and results were consistent among mutation carriers (BRCA1, ovarian cancer HR = 1.09, 95% CI 0.97-1.23, p = 0.14, breast cancer HR = 1.04, 95% CI 0.97-1.12, p = 0.27; BRCA2, ovarian cancer HR = 0.89, 95% CI 0.71-1.13, p = 0.34, breast cancer HR = 1.06, 95% CI 0.94-1.19, p = 0.35). Null results were also obtained for associations with overall survival following ovarian cancer (HR = 0.94, 95% CI 0.83-1.07, p = 0.38), breast cancer (HR = 0.96, 95% CI 0.87-1.06, p = 0.38), and all other previously-reported associations. Conclusions rs61764370 is not associated with risk of ovarian or breast cancer nor with clinical outcome for patients with these cancers. Therefore, genotyping this variant has no clinical utility related to the prediction or management of these cancers.
  •  
8.
  • Huyghe, Jeroen R., et al. (författare)
  • Discovery of common and rare genetic risk variants for colorectal cancer
  • 2019
  • Ingår i: Nature Genetics. - : Nature Publishing Group. - 1061-4036 .- 1546-1718. ; 51:1, s. 76-
  • Tidskriftsartikel (refereegranskat)abstract
    • To further dissect the genetic architecture of colorectal cancer (CRC), we performed whole-genome sequencing of 1,439 cases and 720 controls, imputed discovered sequence variants and Haplotype Reference Consortium panel variants into genome-wide association study data, and tested for association in 34,869 cases and 29,051 controls. Findings were followed up in an additional 23,262 cases and 38,296 controls. We discovered a strongly protective 0.3% frequency variant signal at CHD1. In a combined meta-analysis of 125,478 individuals, we identified 40 new independent signals at P < 5 x 10(-8), bringing the number of known independent signals for CRC to similar to 100. New signals implicate lower-frequency variants, Kruppel-like factors, Hedgehog signaling, Hippo-YAP signaling, long noncoding RNAs and somatic drivers, and support a role for immune function. Heritability analyses suggest that CRC risk is highly polygenic, and larger, more comprehensive studies enabling rare variant analysis will improve understanding of biology underlying this risk and influence personalized screening strategies and drug development.
  •  
9.
  •  
10.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 79
Typ av publikation
Typ av innehåll
refereegranskat (79)
Författare/redaktör
Pharoah, Paul D. P. (56)
Chang-Claude, Jenny (44)
Easton, Douglas F. (44)
Giles, Graham G (41)
Wolk, Alicja (37)
Brenner, Hermann (37)
visa fler...
Rennert, Gad (30)
Hopper, John L. (30)
Milne, Roger L. (29)
Lindblom, Annika (29)
Zheng, Wei (29)
Chanock, Stephen J (27)
Offit, Kenneth (26)
Arndt, Volker (25)
Wu, Anna H. (24)
Peters, Ulrike (24)
Andrulis, Irene L. (24)
Hamann, Ute (24)
Nevanlinna, Heli (23)
Dunning, Alison M. (23)
Benitez, Javier (23)
Chenevix-Trench, Geo ... (23)
Kraft, Peter (23)
Albanes, Demetrius (22)
Newcomb, Polly A. (22)
White, Emily (22)
Haiman, Christopher ... (21)
Couch, Fergus J. (21)
Schmidt, Marjanka K. (21)
Gruber, Stephen B. (20)
Moreno, Victor (20)
Lambrechts, Diether (20)
Southey, Melissa C. (20)
Simard, Jacques (20)
Casey, Graham (19)
Chan, Andrew T. (19)
Hoffmeister, Michael (19)
Li, Li (19)
Bojesen, Stig E. (19)
Hall, Per (19)
Olsson, Håkan (18)
Berndt, Sonja I (18)
John, Esther M (18)
Gunter, Marc J. (18)
Slattery, Martha L. (18)
Woods, Michael O. (18)
Campbell, Peter T. (18)
Dennis, Joe (18)
Cox, Angela (18)
Fasching, Peter A. (18)
visa färre...
Lärosäte
Karolinska Institutet (46)
Uppsala universitet (40)
Umeå universitet (26)
Lunds universitet (24)
Göteborgs universitet (1)
Linköpings universitet (1)
Språk
Engelska (79)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (67)
Naturvetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy